secwatch.observer — SEC 8-K summary
======================================

Issuer:     Claritev Corp (CTEV)
CIK:        0001793229
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001793229-23-000109
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MultiPlan Q2 2023 revenue $238M (-18% YoY), net loss $36.4M, acquires BST
-------------------------------------------------------------------------

- Q2 2023 revenue $238.0M, down 18% from $290.1M in Q2 2022; net loss $36.4M vs net income $13.5M.
- Adjusted EBITDA $152.7M, down from $209.6M in prior-year quarter; Free Cash Flow negative $(24.3)M.
- Acquired Benefits Science Technologies on May 8, 2023 for $141.3M cash, adding new Data & Decision Science service line.
- Updated FY 2023 guidance: revenue $950M-$980M (includes BST), Adjusted EBITDA $615M-$635M.
- Q2 2023 processed $43.1B in claim charges, identifying potential savings of $5.7B; repurchased $7.4M of common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1793229/000179322923000109/0001793229-23-000109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1793229/000179322923000109/mpln-20230802.htm
  HTML page:      https://secwatch.observer/filing/0001793229-23-000109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer